Cargando…
Acetazolamide Mitigates Intracranial Pressure Spikes Without Affecting Functional Outcome After Experimental Hemorrhagic Stroke
Increased intracranial pressure (ICP) after stroke can lead to poor outcome and death. Novel treatments to combat ICP rises are needed. The carbonic anhydrase inhibitor acetazolamide diminishes cerebrospinal fluid (CSF) production, reduces ICP in healthy animals, and is beneficial for idiopathic int...
Autores principales: | Williamson, Michael R., Wilkinson, Cassandra M., Dietrich, Kristen, Colbourne, Frederick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647499/ https://www.ncbi.nlm.nih.gov/pubmed/30225552 http://dx.doi.org/10.1007/s12975-018-0663-6 |
Ejemplares similares
-
Evidence for Decreased Brain Parenchymal Volume After Large Intracerebral Hemorrhages: a Potential Mechanism Limiting Intracranial Pressure Rises
por: Williamson, Michael R., et al.
Publicado: (2017) -
Intraocular and intracranial pressure in glaucoma patients taking acetazolamide
por: Loiselle, Allison R., et al.
Publicado: (2020) -
Prolonged Blood-Brain Barrier Injury Occurs After Experimental Intracerebral Hemorrhage and Is Not Acutely Associated with Additional Bleeding
por: Nadeau, Colby A., et al.
Publicado: (2018) -
Topiramate is more effective than acetazolamide at lowering intracranial pressure
por: Scotton, William J, et al.
Publicado: (2018) -
Intracranial Pressure Dysfunction Following Severe Intracerebral Hemorrhage in Middle-Aged Rats
por: Kalisvaart, Anna C. J., et al.
Publicado: (2022)